# ANKTIVA
> **BLA761336** · Biologics License Application · Sponsor: ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU · Approved 2024-04-22
## Drug
- **FDA Application Number:** BLA761336
- **Application type:** Biologics License Application
- **Brand name:** ANKTIVA
- **Generic name:** NOGAPENDEKIN ALFA INBAKICEPT-PMLN
- **Active ingredients:** nogapendekin alfa inbakicept-pmln
- **Dosage form:** SOLUTION
- **Route:** INTRAVESICAL
- **Marketing status:** Prescription
- **Sponsor:** ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
- **Manufacturer:** Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
- **First approval:** 2024-04-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761336)
---
*MORVS · CC0 1.0*